Alpha 2.0
Login Register
» Articles » PMID: 4748449

The Basis for the Disparate Sensitivity of L1210 Leukemia and Walker 256 Carcinoma to a New Triazine Folate Antagonist

Overview
Journal Cancer Res
Specialty Oncology
Date 1973 Nov 1
PMID 4748449
Citations 3
Authors
R T Skeel
W L Sawicki
A R Cashmore
J R Bertino
Affiliations
Soon will be listed here.
Citing Articles

Phase II study of Baker's antifol (triazinate, TZT, NSC 139, 105) in advanced carcinoma of the ovary. A Gynecologic Oncology Group study.

Arseneau J, Bundy B, Homesley H, Beecham J Invest New Drugs. 1983; 1(2):185-8.

PMID: 6236163 DOI: 10.1007/BF00172079.

Cross resistance to esters of methotrexate in a doxorubicin-resistant subline of P388 murine leukemia.

Ramu A, Fridkin M, Steinherz R Cancer Chemother Pharmacol. 1985; 15(1):31-4.

PMID: 4006047 DOI: 10.1007/BF00257290.

A phase I and pharmacokinetic study of trimetrexate using a 24-hour continuous-injection schedule.

Allegra C, Jenkins J, Weiss R, Balis F, Drake J, Brooks J Invest New Drugs. 1990; 8(2):159-66.

PMID: 2143500 DOI: 10.1007/BF00177251.